Sirnaomics

In News

Sirnaomics Ltd. Strengthens Leadership with New Director Appointments - TipRanks

TipRanks - Jul 02, 2025

Sirnaomics Ltd. Appoints New Auditor Amid Audit Challenges - Nasdaq

Nasdaq - Dec 13, 2024

A Novel Injectable Polypeptide Nanoparticle Encapsulated siRNA Targeting TGF-β1 and COX-2 for Localized Fat Reduction II: Phase I Clinical Trial - Wiley Online Library

Wiley Online Library - Dec 18, 2024

Sirnaomics Ltd. Announces Board of Directors and Their Roles - TipRanks

TipRanks - Jul 02, 2025

Sirnaomics completes IND-enabling trials of siRNA therapy STP125G - Clinical Trials Arena

Clinical Trials Arena - Jul 15, 2024

Sirnaomics: a unique, clinical-phase RNA therapeutic innovator on the global stage - Nature

Nature - May 16, 2022

Sirnaomics Ltd. Announces Board Composition and Committee Roles - TipRanks

TipRanks - Jun 20, 2025

Sirnaomics Strengthens Its Development and Manufacturing Leadership with Promotions of Two Biopharma Veterans, Dr. Steven Long and Dr. Edward Wang - PR Newswire

PR Newswire - Dec 14, 2021

Coronavirus: China tests AbbVie’s HIV drugs; Sirnaomics to develop drugs - Pharmaceutical Technology

Pharmaceutical Technology - Jan 27, 2020

MoCo biopharma Sirnaomics more than triples footprint with new HQ - The Business Journals

The Business Journals - Dec 20, 2022

Sirnaomics gears up for Phase III isSCC trial - Clinical Trials Arena

Clinical Trials Arena - Jun 20, 2023

Sirnaomics closes second portion of $47M Series C round for RNA-interference drugs - MedCity News

MedCity News - Apr 29, 2019

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.